Literature DB >> 24474611

Risk of several cancers is higher in urban areas after adjusting for socioeconomic status. Results from a two-country population-based study of 18 common cancers.

Linda Sharp1, David Donnelly, Avril Hegarty, Anne-Elie Carsin, Sandra Deady, Neil McCluskey, Anna Gavin, Harry Comber.   

Abstract

Some studies suggest that there are urban-rural variations in cancer incidence but whether these simply reflect urban-rural socioeconomic variation is unclear. We investigated whether there were urban-rural variations in the incidence of 18 cancers, after adjusting for socioeconomic status. Cancers diagnosed between 1995 and 2007 were extracted from the population-based National Cancer Registry Ireland and Northern Ireland Cancer Registry and categorised by urban-rural status, based on population density of area of residence at diagnosis (rural <1 person per hectare, intermediate 1-15 people per hectare, urban >15 people per hectare). Relative risks (RR) were calculated by negative binomial regression, adjusting for age, country and three area-based markers of socioeconomic status. Risks were significantly higher in both sexes in urban than rural residents with head and neck (males RR urban vs. rural = 1.53, 95 % CI 1.42-1.64; females RR = 1.29, 95 % CI 1.15-1.45), esophageal (males 1.21, 1.11-1.31; females 1.21, 1.08-1.35), stomach (males 1.36, 1.27-1.46; females 1.19, 1.08-1.30), colorectal (males 1.14, 1.09-1.18; females 1.04, 1.00-1.09), lung (males 1.54, 1.47-1.61; females 1.74, 1.65-1.84), non-melanoma skin (males 1.13, 1.10-1.17; females 1.23, 1.19-1.27) and bladder (males 1.30, 1.21-1.39; females 1.31, 1.17-1.46) cancers. Risks of breast, cervical, kidney and brain cancer were significantly higher in females in urban areas. Prostate cancer risk was higher in rural areas (0.94, 0.90-0.97). Other cancers showed no significant urban-rural differences. After adjusting for socioeconomic variation, urban-rural differences were evident for 12 of 18 cancers. Variations in healthcare utilization and known risk factors likely explain some of the observed associations. Explanations for others are unclear and, in the interests of equity, warrant further investigation.

Entities:  

Mesh:

Year:  2014        PMID: 24474611      PMCID: PMC4074316          DOI: 10.1007/s11524-013-9846-3

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  48 in total

1.  Urban-rural differences in breast cancer incidence in Egypt (1999-2006).

Authors:  Subhojit Dey; Amr S Soliman; Ahmad Hablas; Ibrahim A Seifeldein; Kadry Ismail; Mohamed Ramadan; Hesham El-Hamzawy; Mark L Wilson; Mousumi Banerjee; Paolo Boffetta; Joe Harford; Sofia D Merajver
Journal:  Breast       Date:  2010-05-08       Impact factor: 4.380

2.  Where do people with lung cancer die and how is this changing? A population-based study.

Authors:  L Sharp; P Foll; S Deady; A O'Ceilleachair; C Buicke; A E Carsin
Journal:  Ir Med J       Date:  2010-10

3.  Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional, multilevel study.

Authors:  Peter D Baade; Gavin Turrell; Joanne F Aitken
Journal:  J Epidemiol Community Health       Date:  2011-01-30       Impact factor: 3.710

4.  The low uptake of breast screening in cities is a major public health issue and may be due to organisational factors: a Census-based record linkage study.

Authors:  H Kinnear; M Rosato; A Mairs; C Hall; D O'Reilly
Journal:  Breast       Date:  2011-05-20       Impact factor: 4.380

5.  Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland.

Authors:  A E Carsin; L Sharp; H Comber
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

6.  Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland.

Authors:  A-E Carsin; F J Drummond; A Black; P J van Leeuwen; L Sharp; L J Murray; D Connolly; L Egevad; M Boniol; P Autier; H Comber; A Gavin
Journal:  Cancer Causes Control       Date:  2010-06-01       Impact factor: 2.506

7.  Have developments in palliative care services impacted on place of death of colorectal cancer patients in Ireland? A population-based study.

Authors:  A Ó Céilleachair; C Finn; S Deady; A-E Carsin; L Sharp
Journal:  Ir J Med Sci       Date:  2010-10-17       Impact factor: 1.568

8.  Rural/urban mortality differences in England and Wales and the effect of deprivation adjustment.

Authors:  Andrea Gartner; Daniel Farewell; Paul Roach; Frank Dunstan
Journal:  Soc Sci Med       Date:  2011-03-30       Impact factor: 4.634

9.  Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004.

Authors:  V R Doherty; D H Brewster; S Jensen; D Gorman
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

10.  Geographic remoteness and risk of advanced colorectal cancer at diagnosis in Queensland: a multilevel study.

Authors:  P D Baade; P Dasgupta; J Aitken; G Turrell
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

View more
  17 in total

1.  Lifetime excess cancer risk due to carcinogens in food and beverages: Urban versus rural differences in Canada.

Authors:  Roslyn Cheasley; C Peter Keller; Eleanor Setton
Journal:  Can J Public Health       Date:  2017-09-14

2.  A population-based analysis of urban-rural disparities in advanced pancreatic cancer management and outcomes.

Authors:  Thomas D Canale; HyoKeun Cho; Winson Y Cheung
Journal:  Med Oncol       Date:  2018-07-04       Impact factor: 3.064

3.  Food Habits, Lifestyle Factors, and Risk of Prostate Cancer in Central Argentina: A Case Control Study Involving Self-Motivated Health Behavior Modifications after Diagnosis.

Authors:  Sandaly O S Pacheco; Fabio J Pacheco; Gimena M J Zapata; Julieta M E Garcia; Carlos A Previale; Héctor E Cura; Winston J Craig
Journal:  Nutrients       Date:  2016-07-09       Impact factor: 5.717

4.  Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.

Authors:  Harry Comber; Marianna De Camargo Cancela; Trutz Haase; Howard Johnson; Linda Sharp; Jonathan Pratschke
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

5.  Urban-Rural Variations in Quality-of-Life in Breast Cancer Survivors Prescribed Endocrine Therapy.

Authors:  Caitriona Cahir; Audrey Alforque Thomas; Stephan U Dombrowski; Kathleen Bennett; Linda Sharp
Journal:  Int J Environ Res Public Health       Date:  2017-04-07       Impact factor: 3.390

6.  Time trends in prostate cancer screening in Swiss primary care (2010 to 2017) - A retrospective study.

Authors:  Stefan Zechmann; Stefania Di Gangi; Vladimir Kaplan; Rahel Meier; Thomas Rosemann; Fabio Valeri; Oliver Senn
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

Review 7.  Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation.

Authors:  Alexandra Amaro-Ortiz; Betty Yan; John A D'Orazio
Journal:  Molecules       Date:  2014-05-15       Impact factor: 4.411

8.  Regional Inequalities in Lung Cancer Mortality in Belgium at the Beginning of the 21st Century: The Contribution of Individual and Area-Level Socioeconomic Status and Industrial Exposure.

Authors:  Paulien Hagedoorn; Hadewijch Vandenheede; Didier Willaert; Katrien Vanthomme; Sylvie Gadeyne
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

9.  Light and the City: Breast Cancer Risk Factors Differ Between Urban and Rural Women in Israel.

Authors:  Atalya Keshet-Sitton; Keren Or-Chen; Sara Yitzhak; Ilana Tzabary; Abraham Haim
Journal:  Integr Cancer Ther       Date:  2016-07-20       Impact factor: 3.279

10.  Heterogeneity in the Relationship between Disinfection By-Products in Drinking Water and Cancer: A Systematic Review.

Authors:  Tarik Benmarhnia; Ianis Delpla; Lara Schwarz; Manuel J Rodriguez; Patrick Levallois
Journal:  Int J Environ Res Public Health       Date:  2018-05-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.